PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME

This adverse event was reported 6 times

These drugs are most commonly taken by patients reporting PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME:

# Drug Count
0 FILGRASTIM 5
1 ADALIMUMAB 4
2 ADALIMUMAB-AATY 4
3 ADALIMUMAB-ADAZ 4
4 ADALIMUMAB-FKJP 4
5 ALEMTUZUMAB 4
6 ANAKINRA 4
7 CANAKINUMAB 4
8 CYCLOSPORINE 4
9 ETANERCEPT 4
See all common drugs associated with PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME

PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TREOSULFAN 4 0.0014
1 THIOTEPA 4 0.0004
2 CANAKINUMAB 4 0.0004
3 GOLIMUMAB 4 0.0003
4 ANAKINRA 4 0.0002
5 ALEMTUZUMAB 4 0.0002
6 FILGRASTIM 5 0.0001
7 FLUDARABINE PHOSPHATE 4 0.0001
8 ADALIMUMAB-FKJP 4 0.0001
9 ADALIMUMAB-AATY 4 0.0001
See all drugs enriched for association with PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME